I deal in facts.
Fact: The original patent application listed NNLX as the Assignee
Fact: Bret changed the assignment to HIS name from the company's.
Fact: the whole argument about the assignment being a clerical error is moot. It came from a board poster who allegedly talked to BB.
Fact: No one is arguing who invented it.
Fact: At NO TIME has the royalty amount ever been put out in a statement from the company. For all we know BB might be taking %50, 70, 90% as a royalty fee. If he has nothing to hide let him post his royalty fee he gets from each flatpack case, in financials. Then the shareholders will know. Do you object to posting Financials?
Not wishing to argue with you NanoFan. But since this has been going on for a long time now, it would appear that there aren't too many investors that have the balls to challenge anything as a group. He has the patents, the company makes NO money, Sales are pretty much non-existant, workers have been leaving at a steady rate, no real info is passed on to investors, no shareholder meetings, and no BOD elections. Sounds pretty much like a one man show all for his own benefit. Just my opinion.
Oh and NNLX sits at .0345/share
Excuse me Eric. Check for yourself. The patent for the flatpack is in BB's name. Remember he changed it from the company's name as the assignee to his name. Do your homework. IMO no self respecting CEO would take the companies property and make it his own. Like I said, if NNLX goes belly up - watch what happens to the patent and BB.
All in my opinion.
They did a peer review on a product that NNLX doesn't even own the patent for. The "ONLY" one that benefits from the review is BB himself - NOT the company. If NNLX goes belly up, BB simply walks away with the patent and the peer review and sells it to the highest bidder. You fools need to smarten up and realize your being played for suckers.
Yea..... that's great. All we need now, is for them to actually do "something" and make an announcement. Instead we get..ZZZZZZZZZZZZZZZZzzzzzzzzzzz. Don't see anything new on the horizon, but then again, they don't keep their shareholders or anyone else informed.
If you get an actual chance to talk to someone in "power" as they say. Tell them that the shareholders are quite miffed at the fact they don't put out any news or updates. And they need to do a better job of getting their name out there into the world.
If you get the chance?
Thank's in advance
Oh man, where do I start??? I don't post much anymore, but I do peruse the boards. Erik, 'Ol buddy. You, without a doubt have to be the dumbest #$%$ to roam the planet. Year after year BB, disappoints with proclamation after proclamation and yet.........nothing. Everything and I mean everything that man does with regards to the business of running NNLX turns to lead. Nothing ever happens to increase sales. Staff is leaving or has left on a regular basis. There are NO financial reports put out, NO shareholder meetings, NO BOD elections, nothing. NO word of any kind. There is nothing that BB can say that would have any merit or even a ring of truth to it any more. Everything he has said he (NNLX) was going to do -----just doesn't. Time to wake up and smell the bacon. He is now looking to get MORE suckers to invest. No money, no products, dead horse.
As always, Just my opinion.
That's what happens when you sit in the shadows and don't even make a "peep" to let others know of your (as in the company's) existence.
C'mon Adel, do something constructive to bring AVAX, OUT of the shadows and into the main stream.
From what I have seen, the CTCA ads where I live, are dealing more with Gene therapy as opposed to immunotherapy. Still don't think CTCA is here to help AVAX (since their dust up) as it is to just collect the money "if" things go well.
AVAX needs to get off their collective a**es and inform the shareholders of what is going on with financing and trials. New CEO or not they shouldn't go back to the way they were.
Just my opinion though.
First - they do NOT inform their shareholders of any new developments.
Second - if they're are NO new development then Mgt. are not doing enough to make progressions in bringing product to market/trials and promote AVAX's treatment.
Third - they don't even reply to e-maiils. (unless of course you are going to be a large pipe shareholder.
Yup, pink ears. But they're on BB's head. Caused from shareholders slapping him up-side the head for mismanaging NNLX into the ground. What's that smell????? Oh yea, dilution, dilution, dilution. Company is close to broke and BB will walk away with the patents in hand.
Just my opinion.
This company can't/won't even give out an update on the state of affairs of the company, let alone a PR on new trials. Can't see where the new Mgt. is doing any better than the old Mgt.